Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real?
Hyperuricemia (HU) and gout are independent risk factors for chronic kidney disease (CKD). Worldwide, the increasing prevalence of CKD leads to a deterioration in the quality and duration of life of patients and an increase in mortality. If HU plays a significant role in the development of renal fai...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
IMA-PRESS LLC
2024-10-01
|
| Rangatū: | Современная ревматология |
| Ngā marau: | |
| Urunga tuihono: | https://mrj.ima-press.net/mrj/article/view/1651 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|